Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial

Denosumab, a RANKL inhibitor, reduced the risk of vertebral, hip, and nonvertebral fractures in the Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months (FREEDOM) trial of postmenopausal women with osteoporosis compared with placebo. Previous bone histomorphometric analysis in F...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Bone Miner Res
Main Authors: Chavassieux, Pascale, Portero‐Muzy, Nathalie, Roux, Jean Paul, Horlait, Stéphane, Dempster, David W, Wang, Andrea, Wagman, Rachel B, Chapurlat, Roland
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850394/
https://ncbi.nlm.nih.gov/pubmed/30601581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.3631
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker